Form D · Other Investment Fund
Innovatus Life Sciences Lending Fund I, LP
New York, NY · CIK 0001692825
Offering snapshot reported Mar 21, 2025 · SEC filing
- Reported sold
- $190M Indefinite offering
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $2M Reported outside-investor minimum
- First sale
- Feb 7, 2017 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2025 | Amendment | $190,143,986 | $0vs Mar 22, 2024 | 32 | SEC filing |
| Mar 22, 2024 | Amendment | $190,143,986 | $0vs Mar 24, 2023 | 32 | SEC filing |
| Mar 24, 2023 | Amendment | $190,143,986 | $21,765,000vs Mar 25, 2022 | 32 | SEC filing |
| Mar 25, 2022 | Amendment | $168,378,986 | $0vs Mar 26, 2021 | 27 | SEC filing |
| Mar 26, 2021 | Amendment | $168,378,986 | $26,702,234vs Mar 27, 2020 | 27 | SEC filing |
| Mar 27, 2020 | Amendment | $141,676,752 | $33,353,135vs Mar 29, 2019 | 13 | SEC filing |
| Mar 29, 2019 | Amendment | $108,323,617 | -$1,145,055vs Mar 16, 2018 | 14 | SEC filing |
| Mar 16, 2018 | Amendment | $109,468,672 | No comparison | 8 | SEC filing |
| Mar 17, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-282837
Clarification of Item 11 - The General Partner, in consultation with the Manager, may accept commitments of lesser amounts.
Source: Form D, filed Mar 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Dym | Executive |
| Andrew Hobson | Executive |
| N/A Innovatus Capital Partners, Llc | Promoter |
| N/A Innovatus Flagship Parent Gp, Llc | Executive |
| N/A Innovatus Life Sciences Gp, Lp | Executive |
| David Schiff | Executive |
| Joseph Schottland | Executive |
| Sean Wilke | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10017